LEXICON PHARMACEUTICALS, INC. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

LEXICON PHARMACEUTICALS, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $6.00 million for the year ending 2024.

  • LEXICON PHARMACEUTICALS, INC. showed an increase of +440.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2023 to 2024.
  • This data is from LEXICON PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 7, 2025.
  • XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2024: $6.00 million | Fiscal year 2023: $1.11 million | Fiscal year 2022: $0.00 | Fiscal year 2021: $0.00 | Fiscal year 2020: $23.40 million | Fiscal year 2019: $32.33 million | Fiscal year 2018: $26.58 million | Fiscal year 2017: $15.89 million | Fiscal year 2016: $0.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: